Inventor · disambiguated record
Rongze Kuang
Also filed as: KUANG RONGZE
24 granted patents·8 pending applications·63 citations·filing 1997–2025
93Inventor score
Files withMERCK SHARP & DOHME14MERCK SHARP & DOHME LLC9TING PAULINE C3SCHERING CORP2BOYCE CHRISTOPHER W1
Top patents by PatentIndex Score
32 records- 0191US7511062B2Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitorsSCHERING CORP·Filed 2005·Granted Mar 31, 2009·31 cites·29 claims
- 0283US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 0383US9868727B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·3 cites·16 claims
- 0481US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 0580US7956189B2Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process thereforeSCHERING CORP·Filed 2007·Granted Jun 7, 2011·7 cites·10 claims
- 0679US9783530B2Factor Xla inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 10, 2017·2 cites·14 claims
- 0777US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 0876US10011585B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·2 cites·12 claims
- 0975US10822338B2Substituted aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 3, 2020·2 cites·17 claims
- 1074US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 1173US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 1272US2025382300A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1369US2025387397A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1466US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 1563US8232274B2Pyridazinone derivatives useful as glucan synthase inhibitorsTING PAULINE C·Filed 2008·Granted Jul 31, 2012·1 cites·20 claims
- 1661US12414952B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 1760US12466831B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 11, 2025·0 cites·14 claims
- 1855US12428397B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Sep 30, 2025·0 cites·13 claims
- 1955US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 2054US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 2154US2024076297A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2253US12459927B2Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 4, 2025·0 cites·16 claims
- 2353US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 2452US2011224193A1Inhibitors of diacylglycerol acyltransferaseMERCK SHARP & DOHME·Filed 2009·Application pending·0 cites
- 2551US12304899B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted May 20, 2025·0 cites·13 claims
- 2651US2023416227A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2747US8716312B2Inhibitors of diacylglycerol acyltransferaseTING PAULINE C·Filed 2009·Granted May 6, 2014·0 cites·6 claims
- 2847US2011224136A1Inhibitors of diacylglycerol acyltransferaseTING PAULINE C·Filed 2009·Application pending·0 cites
- 2943US11046714B22,2-difluorodioxolo A2A receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jun 29, 2021·0 cites·14 claims
- 3041US10143681B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 4, 2018·0 cites·16 claims
- 3135US2014088124A1Imidazole derivativesDEVITA ROBERT J·Filed 2012·Application pending·0 cites
- 3229US6420401B11,2,5, thiadiazolidin-3-one 1,1-dioxide derivativesUNIV WICHITA STATE·Filed 1997·Granted Jul 16, 2002·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Rongze Kuang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →